Furthermore, sulbactam is a semisynthetic beta lactamase inhibitor that has been commonly used in conjunction with intravenous ampicillin [20] to avoid secondary infection in patients with cytokine adsorption in severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV). This evidence concerns the gene LACTB and infection.